stoxline Quote Chart Rank Option Currency Glossary
ProSomnus, Inc. Common Stock (OSA)
0.47  0 (0%)    07-15 16:00
Open: 0.5
High: 0.5
Volume: 58,854
Pre. Close: 0.47
Low: 0.47
Market Cap: 8(M)
Technical analysis
2024-07-16 10:51:19 AM
Short term     
Mid term     
Targets 6-month :  0.58 1-year :  0.68
Resists First :  0.5 Second :  0.58
Pivot price 0.03
Supports First :  0.19 Second :  0
MAs MA(5) :  0.09 MA(20) :  0.03
MA(100) :  0.3 MA(250) :  0.71
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  33.2 D(3) :  13.5
RSI RSI(14): 92.5
52-week High :  2.75 Low :  0
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ OSA ] has closed above the upper band by 43.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 128.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.01 - 0.01 0.01 - 0.01
Low: 0 - 0 0 - 0
Close: 0 - 0.01 0.01 - 0.01
Company Description

Prosomnus Sleep Technologies, Inc. designs, manufactures, and markets sleep apnea therapy devices for dentists to treat patients diagnosed with obstructive sleep apnea. The company was incorporated in 2016 and is based in Pleasanton, California.

Headline News

Thu, 27 Jun 2024
Kintara Therapeutics restructures share designations By -

Thu, 09 May 2024
Key healthcare product maker files for Chapter 11 bankruptcy - TheStreet

Thu, 22 Feb 2024
Positive Sentiment Still Eludes ProSomnus, Inc. (NASDAQ:OSA) Following 35% Share Price Slump - Simply Wall St

Tue, 10 May 2022
ProSomnus to Be Listed as ‘OSA’ on Nasdaq After Combining with Lakeshore Acquisition - Sleep Review

Tue, 16 Jul 2024

Tue, 16 Jul 2024

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 17 (M)
Shares Float 8 (M)
Held by Insiders 20.6 (%)
Held by Institutions 57 (%)
Shares Short 74 (K)
Shares Short P.Month 153 (K)
Stock Financials
EPS -1.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.2
Profit Margin -87.2 %
Operating Margin -64 %
Return on Assets (ttm) -40.2 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 35.2 %
Gross Profit (p.s.) 0
Sales Per Share 1.58
EBITDA (p.s.) -0.99
Qtrly Earnings Growth 0 %
Operating Cash Flow -16 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -0.32
PEG Ratio 0
Price to Book value -0.22
Price to Sales 0.29
Price to Cash Flow -0.51
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android